Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index; 63 of the 114 sources its claims cite were checked for support.
Abstract
Iron deficiency anaemia (IDA) is a worldwide healthcare problem affecting approximately 25% of the global population. The most common IDA treatment is oral iron supplementation, which has been associated with gastrointestinal (GI) side effects such as constipation and bloating. These can result in treatment non-adherence and the persistence of IDA. Intravenous iron does not cause GI side effects, which may be due to the lack of exposure to the intestinal lumen. Luminal iron can cause changes to the gut microbiota, aiding the promotion of pathogenic species and decreasing beneficial protective species. Iron is vital for methanogenic archaea, which rely on iron for growth and metabolism. Increased intestinal methane has been associated with slowing of intestinal transit, constipation, and bloating. Here we explore the literature to understand a potential link between iron and methanogenesis as a novel way to understand the mechanism of oral iron supplementation induced GI side effects.
Overview
CoChat Summary
TL;DR
This narrative review argues that oral iron supplementation causes gastrointestinal side effects partly through unabsorbed luminal iron altering the gut microbiota and potentially promoting methanogenic archaea and methane production, which is linked to constipation and slow transit. It synthesizes evidence on iron absorption, inflammation, microbiota, and methane-modulating strategies, but the mechanism remains unproven.
Key findings
- IDA affects up to 25% of the worldwide population (~2 billion people); in the U.K. it costs the NHS £55.48 million and causes 57,000 hospital admissions annually. Oral iron causes GI side effects in up to 60% of users, and up to 50% do not follow treatment; IV iron has lower rates of nausea (1.6% vs. 4.9%), vomiting (1.0% vs. 6.8%), abdominal pain (1.3% vs. 7.9%), and diarrhoea (0.9% vs. 8.3%).
- Recommended ferrous sulphate 200 mg (65 mg elemental iron) two or three times daily can deliver up to 195 mg elemental iron/day, but only up to 25 mg/day can be absorbed under extreme iron deficiency; the typical adult diet contains 8–15 mg iron/day, with 1–2 mg absorbed daily.
- Iron supplementation/fortification shifts the gut microbiota: increased enteropathogens such as *Salmonella*, *Shigella*, and *Escherichia coli*, and decreased *Lactobacillus*; Kenyan infants showed increased *Enterobacteriaceae* and decreased *Lactobacillus* and *Bifidobacterium*. Iron fortification (~8 mg/day) in African children produced similar adverse shifts.
- The authors hypothesize that iron supports methanogenic species and methanogenesis; methane is associated with slower intestinal transit and constipation. Methanogens are believed present in 30–50% of the population, and potential methane-reducing options discussed include rifaximin plus neomycin, lovastatin, Atrantil (88% response in constipation-predominant IBS), *L. reuteri*, multistrain probiotics (reduced whole gut transit by 13.75 h), and seaweed in cattle (up to 70–95% methane reduction), though human evidence is lacking.
Methods
- Narrative review of the literature; no primary data collection, systematic search strategy, or meta-analysis is reported.
- Synthesizes human, animal, in vitro, and environmental/microbiology evidence on iron absorption and dosing, iron-induced oxidative stress and inflammation, gut microbiota changes, methanogens and methanogenesis, and methane-modulating treatments.
- Main output is a hypothesis linking oral iron-induced GI side effects to iron-driven changes in the gut microbiota and methanogenic archaea/methane production.
Limitations
- Stated: the mechanism by which oral iron supplements cause adverse GI effects is unknown; long-term effects of iron supplementation/fortification on the gut microbiota are unknown; whether methane causes or is a consequence of constipation is uncertain; there is no evidence for seaweed reducing methane in humans; and besides antibiotics, little evidence supports effective methane reduction or methanogen eradication.
- Evident: as a narrative review, it lacks systematic search, inclusion criteria, and quality appraisal; the central iron–methanogen–GI symptom link is hypothesis-generating and not directly tested in the paper.
- Evident: many cited findings come from non-human contexts (e.g., cattle, environmental methanogenesis) or specific populations (infants, IBD patients), limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
48 Valid · 5 Not valid · 30 Not checked · 15 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, an important unexplained clinical limitation of oral iron therapy is that it often causes significant gastrointestinal (GI) side effects such as constipation, abdominal pain, nausea, and bloating [5-7].”
- Also stated in: § 1. Introduction · plain
“an important unexplained clinical limitation of oral iron therapy is that it often causes significant gastrointestinal (GI) side effects such as constipation, abdominal pain, nausea, and bloating [5-7].”
- Also stated in: § Oral Iron Supplementation-Gastrointestinal Side Effects and the Impact on the Gut Microbiota · plain
“The most common IDA treatment is oral iron supplementation, which has been associated with gastrointestinal (GI) side effects such as constipation and bloating.”
What the sources say
- Partly supportedcites [5] 5. Santiago, P. Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview. Sci. World J. 2012 , 2012 , 846824. [CrossRef] sourceExperimental — accuracy not yet measured
The Tolerability section (page unavailable) describes gastrointestinal side effects as a common limitation of oral iron therapy and specifically lists nausea, pain, and constipation. It does not list bloating or establish that the limitation is unexplained; it instead associates the incidence of side effects with unnecessarily high iron doses. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [6] 6. Grzywacz, A.; Lubas, A.; Fiedor, P.; Fiedor, M.; Niemczyk, S. Safety and Efficacy of Intravenous Administration of Iron Preparations. Acta Pol. Pharm 2017 , 74 , 13-24. [PubMed]
- Partly supportedcites [7] 7. Low, M.S.Y.; Speedy, J.; Styles, C.E.; De-Regil, L.M.; Pasricha, S.-R. Daily Iron Supplementation for Improving Anaemia, Iron Status and Health in Menstruating Women. Cochrane Database Syst. Rev. 2016 . [CrossRef] sourceExperimental — accuracy not yet measured
The 'Any gastrointestinal side effects' and 'Hard stools/constipation' sections report increased rates among women taking iron. The 'Abdominal pain' section finds no definitive increase, and the Main results find no evidence of increased nausea; the retrieved passages do not address bloating. The review therefore supports the general GI-side-effect claim, but not every symptom in the list as an established effect. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Oral iron is the most common treatment for ID and IDA due to its low cost, high bioavailability and effectiveness [5,6].”
What the sources say
- Partly supportedcites [5] 5. Santiago, P. Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview. Sci. World J. 2012 , 2012 , 846824. [CrossRef] sourceExperimental — accuracy not yet measured
The Introduction calls oral iron the first choice for replacing iron stores and describes it as inexpensive and effective. Section 2 supports good bioavailability for ferrous sulphate specifically, but says ferric preparations have substantially lower bioavailability. The claim overgeneralizes that property to oral iron as a whole. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [6] 6. Grzywacz, A.; Lubas, A.; Fiedor, P.; Fiedor, M.; Niemczyk, S. Safety and Efficacy of Intravenous Administration of Iron Preparations. Acta Pol. Pharm 2017 , 74 , 13-24. [PubMed]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Up to 60% of people taking oral iron supplements report gastrointestinal side effects [10].”
What the sources say
- Partly supportedcites [10] 10. Cançado, R.D.; Muñoz, M. Intravenous Iron Therapy: How Far Have We Come? Rev. Bras. Hematol. Hemoter. 2011 , 33 , 461-469. [CrossRef] sourceExperimental — accuracy not yet measured
The Introduction reports gastrointestinal adverse-event rates of 35% to 59% with ferrous sulfate, which supports the approximate upper figure of 60%. It also says other oral iron preparations can be better tolerated, so the reported rate should not be generalized to oral iron supplements as a whole. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“patients that receive IV iron infusions report a lower occurrence of these side effects [10] such as nausea (1.6% vs. 4.9%), vomiting (1.0% vs. 6.8%), abdominal pain (1.3% vs. 7.9%), and diarrhoea (0.9% vs. 8.3%) [4].”
What the sources say
- Supportedcites [10] 10. Cançado, R.D.; Muñoz, M. Intravenous Iron Therapy: How Far Have We Come? Rev. Bras. Hematol. Hemoter. 2011 , 33 , 461-469. [CrossRef] source
The Conclusions (page not available) describe a high rate of gastrointestinal adverse events with oral iron and identify IV iron as an option when oral iron causes adverse events. This supports the lower-occurrence comparison attributed to this source; the specific percentages are attached to a separate citation [4] and are not assessed here. (LLM, conf=0.86)
- Supportedcites [4] 4. Bonovas, S.; Fiorino, G.; Allocca, M.; Lytras, T.; Tsantes, A.; Peyrin-Biroulet, L.; Danese, S. Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine 2016 , 95 , e2308. [CrossRef] [PubMed] source
The Results section (Gastrointestinal Adverse Events) reports lower rates in the IV iron groups for all four listed symptoms, with exactly the percentages quoted. The comparison concerns adults with inflammatory bowel disease receiving iron for anemia. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the Fenton reaction, reactive oxygen species (ROS) such as hydrogen peroxide (H2O2) are reduced by electrons to produce free radical species such as hydroxyl ions (OH -) [37,39].”
What the sources say
- Not matchedcites [37] 37. Junqueira Franco, M.M.V.; Nicoletti, C.F.; Nonino, C.B.; Vannucchi, H.; Marchini, J.S. Oxidative Stress after Iron Supplementation in Crohn's Disease. J. Clin. Case Rep. 2016 , 6 , 2. [CrossRef]
We searched by its title and found no matching paper.
- Partly supportedcites [39] 39. Ding, H.; Yu, X.; Chen, L.; Han, J.; Zhao, Y.; Feng, J. Tolerable Upper Intake Level of Iron Damages the Intestine and Alters the Intestinal Flora in Weaned Piglets. Metallomics 2020 , 12 , 1356-1369. [CrossRef] sourceExperimental — accuracy not yet measured
The discussion under “Divalent metal ion transporter 1 (DMT-1) plays a role in” says iron-catalyzed Fenton reactions produce active oxygen. It does not specify hydrogen peroxide, electron reduction, or hydroxyl ions as a product of the reaction. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
34 more claims · 15 with their cited sources checked
Create a free account to see all 98 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 43
- Probably not a substantial claim. 21
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 5. Methanogens, Methanogenesis, and GI Symptoms
“Oro-caecal and whole gut transit time significantly decrease in methane producers compared to nonmethane producers [56]”
§ 7. Modulating Methane and Methanogens
“An increase in methane is a direct biomarker that correlates with slow transit”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Oral Iron Supplementation-Gastrointestinal Side Effects and the Impact on the Gut Microbiota
“Intravenous iron does not cause GI side effects”
§ 1. Introduction
“patients that receive IV iron infusions report a lower occurrence of these side effects [10] such as nausea (1.6% vs. 4.9%), vomiting (1.0% vs. 6.8%), abdominal pain (1.3% vs. 7.9%), and diarrhoea (0.9% vs. 8.3%) [4].”
Citations
Cites
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency anaemia (IDA) affects up to 25% of the worldwide population [1], or approximately 2 billion people [2].”
BackgroundRifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Tolkien, Z., Stecher, L., Mander, A. P., Pereira, D. I. A., & Powell, J. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117383 · Cited by 833 · cited 4×
“First-line treatment is recommended to be ferrous sulphate two or three times per day, totalling a daily maximum elemental iron dosage of 195 mg [9,10].”
BackgroundInfluentialJaeggi, T., Kortman, G. A. M., Moretti, D., Chassard, C., Holding, P., Dostal, A., Boekhorst, J., Timmerman, H. M., Swinkels, D. W., Tjalsma, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307720 · Cited by 622 · cited 1×
“Studies investigating the effect of iron supplementation in Kenyan infants also found increased levels of Enterobacteriaceae and decreased levels of Lactobacillus and Bifidobacterium [42].”
BackgroundMoretti, D., Goede, J. S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D. W., & Zimmermann, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-642223 · Cited by 547 · cited 3×
“Moretti et al. 2015 [33] found that high doses of oral iron supplements cause an increase in hepcidin, which inhibits iron absorption for up to 24 h.”
BackgroundZimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · cited 2×
“Archaeal species could also be impacted by iron, and it has been hypothesised that ferrous sulphate, a more soluble form of iron, could augment methanogenic species growth [41].”
BackgroundPimentel, M., Lin, H. C., Enayati, P., van den Burg, B., Lee, H.-R., Chen, J. H., Park, S., Kong, Y., & Conklin, J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00574.2004 · Cited by 508 · cited 4×
“Methane has been linked with the slowing of intestinal transit [56].”
BackgroundInfluentialKell, D. B., Heyden, E. L., & Pretorius, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01221 · Cited by 460
Diagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 1×
“Despite this, clinical guidance recommends iron deficiency anaemia is treated with oral ferrous sulphate 200 mg tablet, with two or three tablets taken daily to replenish iron levels [24,25].”
BackgroundStoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435 · cited 1×
“Other groups have also confirmed enhanced iron absorption with single dosing once daily or alternate day dosing [33,34,36].”
Background
Research works printed but not linked: 3
- 58. Ojetti, V.; Petruzziello, C.; Migneco, A.; Gnarra, M.; Gasbarrini, A.; Franceschi, F.L. Reuteri in Methane Producer Constipated Patients. Eur. Rev. Med. Pharmacol. Sci. 2017 , 21 , 1702-1708.
- 68. Deere, T.M.; Lessner, F.H.; Duin, E.C.; Lessner, D.J. Building an ancient cofactor: Iron-sulfur cluster biogenesis in methanogenic archaea. 1. In Proceedings of the Diverse Life and its Detection on Different Worlds, Mesa, AZ, USA, 24-28 April 2017; p. 3507.
- 83. Ramakrishnan, M.; Dubey, C.; Tulasi, V.; Kislai, P.; Manohar, N. Investigation of Lovastatin, the Anti-Hypercholesterolemia Drug Molecule from Three Oyster Mushroom Species. Int. J. Biomed. Clin. Sci. 2017 , 2 , 26-31.
Cited by
The role of oral iron in the treatment of adults with iron deficiency
Lo, J. O.-T., Benson, A. E., Martens, K. L., Hedges, M. A., McMurry, H. S., DeLoughery, T. G., Aslan, J. E., & Shatzel, J. J. (2022) · European Journal Of Haematology · doi:10.1111/ejh.13892 · Cited by 102
“a potential side effect that should also be considered in patients undergoing oral iron supplementation.(62)”
BackgroundIron homeostasis in older adults: balancing nutritional requirements and health risks
Zeidan, R. S., Martenson, M. S., Tamargo, J. A., McLaren, C., Ezzati, A., Lin, Y., Yang, J. J., Yoon, H., McElroy, T., Collins, J. F., et al. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100212 · Cited by 66
“Highdosesofironcancausegastrointestinalsideeffectssuch as nausea, constipation, and diarrhea, which can reduce compliance with the supplement regimen [141].”
Anaemia in CKD—treatment standard
Macdougall, I. C. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad250 · Cited by 75
Mazgaj, R., Lipiński, P., Szudzik, M., Jończy, A., Kopeć, Z., Stankiewicz, A. M., Kamyczek, M., Swinkels, D. W., Żelazowska, B., & Starzyński, R. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189930 · Cited by 36
“Oral supplements are commonly used for maintaining iron stores in humans [6].”
BackgroundIron deficiency in athletes: A narrative review
Kuwabara, A. M., Tenforde, A. S., Finnoff, J. T., & Fredericson, M. (2022) · PM&R · doi:10.1002/pmrj.12779 · Cited by 36
Jindal, A., Patil, N. D., Bains, A., Sridhar, K., Inbaraj, B. S., Tripathi, M., Chawla, P., & Sharma, M. (2023) · Foods · doi:10.3390/foods12213898 · Cited by 31
“The consumption of ferrous sulfate has been shown to increase the population of methanogenic species in the gut microbiota, which slows the gastrointestinal transit time and causes constipation [82].”
BackgroundPathophysiology and management of iron deficiency anaemia in pregnancy: a review
Akshaykirthan, J. P., & Somannavar, M. S. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05481-2 · Cited by 37
“It is critical to get medical help right once if any of these symptoms appear [42].”
Postoperative anemia in cardiac surgery patients: a narrative review
Li, M. M., Miles, S. J., Callum, J., Lin, Y., Karkouti, K., & Bartoszko, J. M. (2023) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-023-02650-9 · Cited by 27
Bacteria from the gut influence the host micronutrient status
Kouadio, D. K. D., Wieringa, F. T., Greffeuille, V., & Humblot, C. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2227888 · Cited by 23
“Indeed, it has been shown that iron supplementation can lead to increase in potentially pathogenic Enterobacteriaceae and decrease in Bifidobacteriaceae and Lactobacillaceae which are regarded as having positive health effects (Bloor, Schutte, and Hobson 2021).”
Biofortification of Crops to Fight Anemia: Role of Vacuolar Iron Transporters
Krishna, T. P. A., Ceasar, S. A., & Maharajan, T. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07727 · Cited by 23
Quintana‐Castanedo, L., Maseda, R., Pérez‐Conde, I., Butta, N. V., Manzano, E. M., Acuña, P., Crespo, M. G., Soto, A. B., Jiménez, E., Valencia, J., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015271 · Cited by 25
Wielgosz-Grochowska, J. P., Domański, N., & Drywień, M. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137341 · Cited by 22
“Elevated levels of intestinal CH 4 have been linked to decreased intestinal motility, bloating and constipation [57,58].”
BackgroundBioavailability Assessment of an Iron Formulation Using Differentiated Human Intestinal Caco-2 Cells
Fanzaga, M., Bollati, C., Ranaldi, G., Sucato, S., Fustinoni, S., Roda, G., & Lammi, C. (2023) · Foods · doi:10.3390/foods12163016 · Cited by 17
Uçan, A., Kaya, Z. I., Yılmaz, E. Ö., Vasi, İ., & Özgeyik, M. O. (2023) · Medicine · doi:10.1097/md.0000000000034421 · Cited by 13
“[7] A possible explanation is that unabsorbed iron may cause gut inflammation and iron-induced microbiota changes.[25,26] These frequent side effects could limit patient compliance.”
BackgroundIron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions
Anghel, L., Dinu, C. A., Pătraș, D., Ciubară, A., & Chiscop, I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092934 · Cited by 15
“The typical therapy duration— generally 8 to 12 weeks—presents a difficulty for patients facing pill load or numerous comorbidities [71].”
Asperti, M., Brilli, E., Denardo, A., Gryzik, M., Pagani, F., Busti, F., Tarantino, G., Arosio, P., Girelli, D., & Poli, M. (2021) · American Journal of Hematology · doi:10.1002/ajh.26311 · Cited by 11
Gambaro, R. C., Berti, I. R., Cacicedo, M. L., Gehring, S., Álvarez, V. A., Castro, G. R., Seoane, A., Padula, G., & Islan, G. A. (2022) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2022.105252 · Cited by 9
Recent advances in the formulation strategy to improve iron bioavailability: A review
Rout, S. R., Pradhan, D., Haldar, J., Rajwar, T. K., Dash, P., Dash, C., Kumar, V., Kar, B., Ghosh, G., & Rath, G. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105633 · Cited by 11
Could nanotechnology improve exercise performance? Evidence from animal studies
Lima, M. R. N., Moreira, B. J., Bertuzzi, R., & Lima‐Silva, A. E. (2024) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2024e13360 · Cited by 10
Hernández-Landa, R. E., Lazo, M., Salado, D., Sánchez-Almanzar, E., Cepeda, J., Zare, R., Redha, A. A., & Clifford, T. (2024) · Journal of Science in Sport and Exercise · doi:10.1007/s42978-024-00297-6 · Cited by 12
Mîndrilă, B., Buteică, S.-A., Mîndrilă, I., Mihăiescu, D. E., Mănescu, M. D., & Rogoveanu, I. (2022) · Biomedicines · doi:10.3390/biomedicines10051213 · Cited by 11
“A post-therapeutic decrease in the dry weight of feces excreted by rats in this group can be attributed to constipation, a gastrointestinal side effect also observed with other oral iron supplements [55].”
BackgroundDass, M., Nyako, J., Tortoe, C., Fanou‐Fogny, N., Nago, E. S., Hounhouigan, J. D., Berger, J., Wieringa, F. T., & Greffeuille, V. (2021) · Nutrients · doi:10.3390/nu13072286 · Cited by 11
“Consumption of high doses of iron was shown to induce gastrointestinal side effects [45], but the relationship between iron intake and the risk for infectious diseases (e.”
BackgroundPrasad, T., Singh, J., & Hait, M. (2026) · Discover Sensors · doi:10.1007/s44397-026-00050-4 · Cited by 10
Bahbah, W. A., Omar, Z. A. L., Elshafie, A., mahrous, K. S., & Zefzaf, H. M. S. E. (2025) · Pediatric Research · doi:10.1038/s41390-025-04204-9 · Cited by 10
Bioaccessibility and bioavailability assessment of microalgae-derived minerals for human nutrition
Gao, F., Chen, S., Zhao, X., Besimi, A., Zeder, C., Barbosa, M., von Meyenn, F., & Mathys, A. (2026) · Current Research in Food Science · doi:10.1016/j.crfs.2026.101302 · Cited by 10
“However, FeSO 4 direct use as a dietary iron product is limited by issues such as poor stability during storage, gastrointestinal side effects, and interactions with other dietary components (Bloor et al., 2021).”
Microbiota and nutrition as risk and resiliency factors following prenatal alcohol exposure
Upreti, D., Rouzer, S. K., Bowring, A., Labbe, E., Kumar, R. P., Miranda, R. C., & Mahnke, A. H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1182635 · Cited by 9
“While iron supplementation serves as a promising therapeutic intervention for children with a history of PAE, it is important to note that negative side effects for iron supplementation have been reported, including constipation and bloating following oral administration, likely due to effects on gut microbiota (Bloor…”
BackgroundGvozdenko, A. A., Блинов, А. В., Golik, A. B., Рехман, З. А., Nagdalian, A. A., Filippov, D., Askerova, A., Bocharov, N., Kastarnova, E. S., Hassan, F. A. M., et al. (2024) · ACS Omega · doi:10.1021/acsomega.4c02664 · Cited by 7
Friling, M., García‐Muñoz, A. M., Perrinjaquet-Moccetti, T., Victoria‐Montesinos, D., Pérez-Piñero, S., Abellán-Ruiz, M. S., Luque-Rubia, A. J., García-Guillén, A. I., Cánovas, F., & Ivanir, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012282 · Cited by 9
Caştur, L., & Torun, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-76667-5 · Cited by 7
“One potential explanation is that iron not absorbed could lead to inflammation in the gut and alterations in the gut microbiota due to iron exposure 18 .”
Kaolin clay-based diets for managing livestock's health and methane emission problem
Islam, M. R., Naidu, R., & Biswas, B. (2025) · Applied Clay Science · doi:10.1016/j.clay.2025.107891 · Cited by 7
Janzik, R., Geppert, J., Müller, P., Notz, I., Obstfeld, H., Roth, B., Volpers, A.-M., & Böl, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1663562 · Cited by 15
Anticipating climate impacts on nutrition through climate–crop nutrient modelling
Carducci, B., Guarin, J. R., Karl, K., Ziska, L. H., Yang, M., Fanzo, J., Jägermeyr, J., Ruane, A. C., Hoogenboom, G., Herrero, M., et al. (2025) · Nature Climate Change · doi:10.1038/s41558-025-02470-3 · Cited by 10
“For example, the potential physiological side effects of iron supplements pose considerable challenges 9 , while the consistency required for effective zinc supplementation can be difficult to maintain 10 .”
Zhang, Y. Y., Stockmann, R., Ng, K., & Ajlouni, S. (2023) · Food & Function · doi:10.1039/d3fo00504f · Cited by 7
Usman, D., Abubakar, M. B., Ibrahim, K. G., & Imam, M. U. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122328 · Cited by 7
Ferrous fumarate nanoliposomes: Formulation, characterization, and diffusion profiles
Suryani, A., Laksitorini, M. D., & Sulaiman, . N. S. (2024) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2024.154580 · Cited by 16
“Ferrous fumarate may cause side effects such as gastrointestinal disorders, such as diarrhea, nausea, or constipation [2,6].”
Milk osteopontin has high iron-binding capacity and facilitates iron absorption in intestinal cells
Buhl, E. H., Christensen, B., Pedersen, F. H., & Sørensen, E. S. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-25305 · Cited by 5
Impact of Side Effects on Anemia Therapy Compliance
Ciont, C., Pop, R. M., Pop, L., Vodnar, D. C., Morariu, I. D., Suharoschi, R., & Pop, O. L. (2025) · Nutrients · doi:10.3390/nu17091485 · Cited by 16
“Additionally, delayed gastric emptying exacerbated nausea and heartburn due to prolonged exposure of the esophageal and gastric mucosa to acidic contents [3].”
InfluentialIslam, M. R., Naidu, R., & Biswas, B. (2025) · Applied Geochemistry · doi:10.1016/j.apgeochem.2025.106459 · Cited by 5
Verbunt, E., Corona, M. V., Tunçalp, Ö., Rogers, L. M., Prang, K.-H., Vaughan, C., & Bohren, M. A. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005158 · Cited by 7
EFFICACY ASSESSMENT OF BEETROOT EXTRACT IN REGULATING IRON DEFICIENCY ANEMIA IN ANEMIC RATS
Ali, Z. A., & Bilal, A. (2023) · Pakistan Journal of Science · doi:10.57041/pjs.v75i1.826 · Cited by 7
Jaber, N., Abusara, O. H., Ibrahim, A., & Al-Remawi, M. M. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106840 · Cited by 3
Haghighatseir, E., Heidari, R., Eghlidi, N. S., Karimi, Z., Berenjian, A., & Ebrahiminezhad, A. (2025) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-025-02110-3 · Cited by 3
RetractedKumari, A., Chauhan, A. K., Verma, A., Khalid, S., & Nishad, D. K. (2025) · Bioscience Nanotechnology · doi:10.1186/s44331-025-00003-5 · Cited by 3
Yüksel, M., Aydoğan, M., Doğan, Ö., & Yüksel, M. (2025) · Medicine · doi:10.1097/md.0000000000044084 · Cited by 3
Bioavailability of Functional Iron in Protein Microparticles
Chaiwaree, S., Georgieva, R. T., Deckart, T., Lenz, J., Choonukoolphong, T., Suriyaprom, S., Prapan, A., Cheepchirasuk, N., Prüß, A., Xiong, Y. C., et al. (2026) · Nutrients · doi:10.3390/nu18071102 · Cited by 2
“However, due to gastrointestinal disturbances frequently associated with the use of these preparations, their actual efficacy may be limited [28].”
Cruz, L. D. R., Torres, F. D. M. M., Cotrina, A. D. R. Z., et al. (2022) · Ciencia y enfermería/Ciencia y enfermería · doi:10.29393/ce28-29eilr50029 · Cited by 2
Nutritional Strategies for Treating Iron Malnutrition: Implications on Nutrikinetic Approaches
Chekraverthy, B. K., Pardhe, H. A., Kiran, A. V. V. V. R., & Nagappan, K. (2023) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.11.1.23 · Cited by 3
Subroto, E., Zaida, Z., Indiarto, R., Harlina, P. W., Andoyo, R., Geng, F., & Rahmawati, F. (2024) · International Journal of Food Properties · doi:10.1080/10942912.2024.2311153 · Cited by 2
“[1,2] 5] Therefore, safe and protected iron is needed to meet people’s needs, encapsulated in the form of solid lipid nanoparticles (SLNs).”
Srivastav, A., Kshirsagar, S., Adhav, T., et al. (2024) · Cureus · doi:10.7759/cureus.57108 · Cited by 2
Evaluating the effect of grape syrup on iron deficiency anemia in women: A randomized clinical trial
Pourhakim, R., Emadi, F., Razavi-Dizaji, S., Talei, D., Saber, S. S. E., & Iranzadasl, M. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4185 · Cited by 3
Xu, J., Li, X., Xue, K., Xu, Y., Ye, R., Zhao, J., Fan, X., Shan, L., & Wang, Y. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1472096 · Cited by 2
“These nutrients are crucial for the generation of red blood cells (Bloor et al., 2021; Stein et al., 2016).”
Anemia Management Strategies in Diabetic Kidney Disease: A Comprehensive Review
Upadhye, K. S., & Patidar, H. (2025) · Journal of Diabetology · doi:10.4103/jod.jod_26_24 · Cited by 4
Kahfi, J., Laily, N., Pangestu, A. R., et al. (2023) · Food Research · doi:10.26656/fr.2017.7(s1).14 · Cited by 2
Iron Deficiency in Pregnancy: A Brief Review
Yusuf, Z. U., Dibal, N. I., & Chiroma, S. M. (2023) · Journal of Medical Science · doi:10.20883/medical.e776 · Cited by 2
The Intersection of Heart Failure and Iron Deficiency Anemia: Diagnostic and Therapeutic Approaches
Thammitage, M. B., Moussa, N., Rezvani, A., Dhillon, D. K., Gamarra, M. L. O., Singh, K., Hawwa, A. G., Vincente, A., Kaur, S., Nemalapuri, K. S., et al. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x331380241111091452 · Cited by 1
“Oral iron is inexpensive and widely available, but gastrointestinal side effects such as nausea, constipation, and discomfort, which affect up to 70% of patients, often lead to poor adherence [89].”
Testing and treating anaemia in pregnant women in Bangladesh: a cross-sectional survey
Verbunt, E., Hasan, M. I., Davidson, E. M., Ahmed, S., McLean, A. R. D., Rahman, A. M., Bhuiyan, M. S. A., Tipu, S. M. M. U., Sarker, B. K., Hamadani, J. D., et al. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-002167 · Cited by 4
“26 27 Modern intravenous iron products, such as ferric carboxymaltose, differ from older intravenous iron formulations in that they can be given in a single administration, with an infusion time of 15 minutes.”
Yin, X., Wang, Q., Li, T., Fu, Y., & Zhai, Y. (2025) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2025.111827 · Cited by 1
Camacho, V., Bermudez, J., & Pérez, L. D. (2025) · Journal of Biomaterials Applications · doi:10.1177/08853282251393482 · Cited by 1
“11 Iron encapsulation has emerged as a compelling strategy for overcoming the limitations of conventional iron supplementation and forti fi cation.”
Cuong, O. Q., & Thinh, N. T. N. (2025) · Food Quality and Preference · doi:10.1016/j.foodqual.2025.105829 · Cited by 1
Lin, X.-Y., Li, H.-B., Jiao, D.-D., Zhou, L., Bo, X. U., Juhasz, A. L., Ma, L. Q., & Zhou, D. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141983 · Cited by 1
García‐Erce, J. A., García‐López, S., & Martínez‐Francés, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103691 · Cited by 4
“In contrast, conventional oral iron formulations, such as FeSO 4 , are frequently associated with gastrointestinal adverse events including nausea, vomiting, constipation, and diarrhea, reported in 25–40% of patients [45,46].”
Geneen, L. J., Atha, K., Kimber, C., McClune, W., Doree, C. J., Vendramin, C., Chia, L. W., & Roberts, D. J. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009532.pub3 · Cited by 3
González-Meza, G. M., Elizondo‐Luévano, J. H., Peña‐Borrayo, A., Martínez-Ávila, G. C. G., Garzoli, S., Kačániová, M., García-Márquez, E., & Castillo, S. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.202503651 · Cited by 3
“However, oral ferrous sulfate is frequently undermined by gastrointestinal intolerance, which doubles adverse events compared with placebo or IV iron, leading to 50%–60% discontinuation among users [64, 81].”
Madler, A. K., Hosseini, A. F., Noack, C. E., Dadmohammadi, Y., Abbaspourrad, A., & Lei, X. G. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119759 · Cited by 1
Badkur, P., Agarwal, J., Wadhwani, R., Agarwal, A., Lodhi, B., & Fathima, F. (2023) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2279 · Cited by 1
Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey
Richard, E. S., Hrycyshyn, A., Salman, N., Tharani, A. R., Abbruzzino, A., Smith, J. L., Kachura, J. J., Sholzberg, M., Mosko, J. D., Chadi, S. A., et al. (2023) · Current Oncology · doi:10.3390/curroncol30110714 · Cited by 1
“…in GI cancer patients may be limited because of malabsorption of iron in the intestine, trapped iron within enterocytes due to metabolic disorders induced by inflammatory cytokines, lack of patient adherence because of GI side effects, and longer treatment time needed to increase Hb levels [8,9,19].”
BackgroundCharacteristics of iron-containing dietary products on the Serbian market
Zrnić-Ćirić, M., Mijović, M., & Vidović, B. B. (2023) · Hrana i ishrana · doi:10.5937/hraish2301014z · Cited by 1
Chen, H.-C., Liao, M.-T., Wang, J., Tsai, K., Wu, C., & Lu, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155575 · Cited by 1
“Oral iron supplementation is associated with gastrointestinal side effects [37].”
Bethi, C. M. S., Kumar, M. N., Kalarikkal, S. P., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5103961 · Cited by 1
Banjara, S. K., Radhika, M. S., Mahajan, H., Ananthan, R., Gupta, S. S., Ramanujam, K., Geddam, J. J. B., Reddy, A. V., Vijayalakshmi, G., Sharma, R., et al. (2025) · medRxiv · doi:10.1101/2025.11.22.25340788 · Cited by 1
Anemia feriprivă – manifestare de debut al unei boli celiace oculte
Baciu, A. M., Roşca, A., Căpuşă, C.-S., Iordan, I., & Vlădăreanu, A. M. P. D. (2022) · Oncolog-Hematolog ro · doi:10.26416/onhe.60.3.2022.7153
Adverse drug reactions (ADRs) case studies: Mild ADRs
Al‐Worafi, Y. M., Ming, L. C., Dhabali, A. A., Al-Shami, A. M., & Jaber, A. A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98802-5.00008-x
Uremic Toxins: The Role of the Gut and the Kidneys
Courville, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109845 · Cited by 1
Nirmala, T. V., Balusamy, C., Stephan, F., & Reddy, A. D. (2023) · Current Journal of Applied Science and Technology · doi:10.9734/cjast/2023/v42i214164
Effect of oral iron supplementation on functional capacity in heart failure patients
Tjandra, G. W., & Wulandari, Y. (2023) · World Nutrition Journal · doi:10.25220/10.25220/wnj.v07.i1.0003
Travali, E., Travali, N., Garo, M. L., Colombo, S., Sicari, D., & Carnevali, I. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100637
“Moreover, it is well established that high iron levels imping on intestinal microbiota correlating with diverse side effects, such as diarrhea, abdominal pain, vomiting, etc. (Bloor et al. 2021; Qi et al., 2020).”
BackgroundJain, G. K., Gupta, A., Mishra, A., Chandra, N., Warsi, M. H., Md, S., Karim, S., Parekar, R., & Dhama, A. (2024) · International Journal of Pharmacology · doi:10.3923/ijp.2024.352.360
Iron Metabolism and Its Importance in Sports Science
Chatterjee, A., Kundu, A., & Dutta, A. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-6317-1.ch008
Lichtenstern, C. R., & Akhtar, N. (2024) · Cureus · doi:10.7759/cureus.71565
“It is well established that iron can lead to numerous gastrointestinal (GI) side effects, including nausea, constipation, diarrhea, blackened stools, and changes to the gut microbiome [1,2].”
Spinal Trauma: Part 1; Cervical Trauma
Şanlı, D. E. T., Yıldırım, D., & Çeşme, D. H. (2024) · Türk Radyoloji Seminerleri · doi:10.4274/trs.2024.24154
Sarma, K., & Ajith Kumar, R. (2025) · International Ayurvedic Medical Journal · doi:10.46607/iamj0613052025
Sharma, U., Jadaun, S., Khapudang, R., & Siddiqui, S. (2025) · World sustainability series · doi:10.1007/978-3-031-98200-2_17
Alharbi, B. S., Qaidi, B. Z. A., Alharbi, F. S., Alharbi, A. M., & Alsharif, M. S. (2025) · Cureus · doi:10.7759/cureus.97917
“Nevertheless, IV iron is more resource-intensive, requires healthcare facility visits, carries a risk of infusion-related reactions, and is associated with higher costs compared to oral supplementation [4,6].”
Liposomal Technology: An Approach to Overcome Bioavailability Changes of Foods and Nutraceuticals
Sybachin, A. V., & Le-Deygen, I. M. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674220-00107
Evaluasi Ketepatan Penggunaan Terapi Anemia pada Ibu Hamil di Rumah Sakit Universitas Sebelas Maret
Manurung, D. Y. S., Anjelina, E., & Ikakusumawati, N. D. (2025) · Generics Journal of Research in Pharmacy · doi:10.14710/genres.v6i1.30517
Balogun, M. R., Obi‐Jeff, C., Adelabu, Y. A., Afolabi, B. B., & Ameh, C. (2026) · medRxiv · doi:10.64898/2026.02.11.26346091
Jiang, P., Yang, J., Mao, Y., Wu, L., Li, X., Bian, X., Kuang, J., Li, J., Shi, F., Han, X., et al. (2026) · Nutrients · doi:10.3390/nu18060900 · Cited by 2
“In addition, oral iron intake is frequently associated with gastrointestinal adverse effects, including nausea, constipation, and abdominal pain, which markedly compromise patient compliance [5].”
Kale, N., & Funde, S. S. (2026) · Systems Ethnopharmacology and Sustainable Bioresources · doi:10.1016/j.sesb.2026.100007
Faiz, R., Shah, S. A., Saleem, M., et al. (2026) · Futuristic Biotechnology · doi:10.54393/fbt.v6i1.230
Pasban, A., Mousavi, S., Toupchian, O., & Hesarinejad, M. A. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.149182
Impact of Encapsulated Iron Availability on the Growth Kinetics of Campylobacter jejuni
Olson, E. G., Matiak, E. A., Jendza, J. A., & Ricke, S. C. (2026) · Pathogens · doi:10.3390/pathogens15040400
Belabed, Y., Lopez, B., Escola, J., Gobert, O., Talbot, C., & Carrois, F. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07804-8
Piccolo, V., Cuomo, P., Vivo, M. D., Ciampaglia, R., Pagano, C., Capparelli, R., Maisto, M., & Tenore, G. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-64996-6 · Cited by 1
Gastric Siderosis: A Histopathological Surprise while Evaluating a Case of Dyspepsia
Londhe, M. M., Binny, A., Chandanwale, D. S., et al. (2026) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_902_25
Evans, C., Peterson, R., António, J., & Clark, A. (2026) · Cureus · doi:10.7759/cureus.107451
“Gastrointestinal side effects frequently impair adherence, and the bioavailability of supplemental iron is relatively low [15,32].”
Jans, K., Huebbe, P., Kipp, A. P., & Rimbach, G. (2026) · BioFactors · doi:10.1002/biof.70115
“Excess iron drives methane production by some archaea, Clostridium , and Bacteroides species and is discussed as a potential cause for frequent GI side effects of iron intake, such as constipation and bloating [113].”
InfluentialBarvaliya, M. J., Karun, K. M., Chandrashekar, M. S., Chandan, N., Hegde, H., Sagare, S. S., Ravikumar, B. S., & Roy, S. (2026) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2026.101352
“Thus, iron absorption is affected in most of the anaemic patients which may reduce the impact of oral iron supplementation and may cause gastrointestinal problems [6].”
Zhao, W., Mai, C., Liew, K. B., et al. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500114
Silva, I. D., Augustin, M.-A., Huppertz, T., Low, J. Y. Q., Dick, A., & Chandrapala, J. (2026) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70541 · Cited by 1
“…option for combating Fe deficiency, it has been associated with side effects such as nausea, constipation, teeth staining, poor solubility, reduced bioavailability, bloating, impacts on gut microflora in the gut and limited effectiveness at physiological pH (Bloor et al. 2021 ; Rout et al. 2024 ).”
Pandit, S., & Gupta, D. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20262157
Metadata
- Authors
- Bloor, S. R., Schutte, R., & Hobson, A. R.
- Affiliations
- Anglia Ruskin University (GB)
- Functional Gut Diagnostics, Manchester M2 4NG, UK
- Corresponding author
- Bloor, Sarah R.
- Venue
- Microbiology Research
- Publisher
- MDPI AG
- Published
- 2021-06-12
- Volume
- 12
- Issue
- 2
- Pages
- 491-502
- ISSN
- 2036-7473 (ISSN-L)
- 2036-7481
- OpenAlex
- W3166534408
- Semantic Scholar
- 18caf4b27adb0dbc61502fea459e475a130ff097
- Cited by
- 117
- References
- 93
- Citations by year
- 2026: 37 · 2025: 28 · 2024: 18 · 2023: 23 · 2022: 8 · 2021: 3
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microbiology Research (publishedVersion, cc-by)
- Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- oral iron supplementation, iron deficiency anemia, gastrointestinal adverse effects, constipation, bloating, gut microbiota, methanogenesis, methanogenic archaea, intestinal transit, medication adherence, intravenous iron
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.